佛罗里达州2016-2017年阿片类与兴奋剂使用相关感染住院差异评估
结果显示阿片类使用占73%,兴奋剂占43%,仅兴奋剂占27%;阿片类/兴奋剂联合使用与患者自主出院(PDD)相关(aRR 1.28,95%CI 1.17-1.40),仅兴奋剂使用与院内死亡风险升高相关(aRR 1.26,95%CI 1.03-1.46)。
要点
- PWID感染住院中阿片类使用占73%,兴奋剂占43%,仅兴奋剂占27%。
- 阿片类/兴奋剂联合使用与PDD独立相关(aRR 1.28,95%CI 1.17-1.40)。
- 仅兴奋剂使用与院内死亡风险升高相关(aRR 1.26,95%CI 1.03-1.46)。
核心结论
- 阿片类使用贡献多数IDU相关感染住院,但许多住院也涉及兴奋剂。
- 阿片类/兴奋剂联合使用与PDD相关,仅兴奋剂使用与院内死亡风险升高相关。
研究设计与样本
- 按使用物质(阿片类、兴奋剂或两者)和感染部位分组,评估物质使用与PDD及院内死亡的关系。
主要发现
- 阿片类使用占73%,任何兴奋剂占43%,仅兴奋剂占27%。
- 皮肤软组织感染占50%,脓毒症/菌血症占52%,骨髓炎占10%,心内膜炎占10%。
- 阿片类/兴奋剂联合使用组最年轻、无保险比例最高,心内膜炎(16%)和丙型肝炎(44%)比例最高。
- 阿片类/兴奋剂联合使用组PDD为25%,仅阿片类组为12%。
- 调整模型中,与仅阿片类使用相比,阿片类/兴奋剂联合使用与PDD相关(aRR 1.28,95%CI 1.17-1.40);仅兴奋剂使用与院内死亡风险升高相关(aRR 1.26,95%CI 1.03-1.46)。
临床怎么用
- 对PWID感染住院患者应评估兴奋剂使用,尤其联合阿片类使用者的PDD风险和仅兴奋剂使用者的死亡风险。
- 增加减害干预可帮助预防这些感染,需进一步研究兴奋剂使用障碍相关感染的急性管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The opioid epidemic has led to increases in injection drug use (IDU)-associated infectious diseases; however, little is known about how more recent increases in stimulant use have affected the incidence and outcomes of hospitalizations for infections among people who inject drugs (PWID). METHODS: All hospitalizations of PWID for IDU-associated infections in Florida were identified using administrative diagnostic codes and were grouped by substance used (opioids, stimulants, or both) and site of infection. We evaluated the association between substance used and the outcomes: patient-directed discharge (PDD, or "against medical advice") and in-hospital mortality. RESULTS: There were 22 856 hospitalizations for infections among PWID. Opioid use was present in 73%, any stimulants in 43%, and stimulants-only in 27%. Skin and soft tissue infection was present in 50%, sepsis/bacteremia in 52%, osteomyelitis in 10%, and endocarditis in 10%. PWID using opioids/stimulants were youngest, most uninsured, and had the highest rates of endocarditis (16%) and hepatitis C (44%). Additionally, 25% of patients with opioid/stimulant use had PDD versus 12% for those using opioids-only. In adjusted models, opioid/stimulant use was associated with PDD compared to opioid-only use (aRR 1.28, 95% CI 1.17-1.40). Younger age and endocarditis were also associated with PDD. Compared to opioid-only use, stimulant-only use had higher risk of in-hospital mortality (aRR 1.26, 95% CI 1.03-1.46). CONCLUSIONS: While opioid use contributed to most IDU-associated infections, many hospitalizations also involved stimulants. Increasing access to harm reduction interventions could help prevent these infections, while further research on the acute management of stimulant use disorder-associated infections is needed.
引用
- Serota DP, Bartholomew TS, Tookes HE, et al. Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017. Clin Infect Dis. 2021. PMID: 32886747. doi:10.1093/cid/ciaa1278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。